The global bloodstream infection (BSI) testing market is booming, projected to reach $1042.2 million by 2025, with a 4.9% CAGR. Discover key drivers, trends, and market segmentation in this comprehensive analysis, including insights on leading companies like Abbott, BD, and Roche. Explore rapid diagnostic tests (RDTs), molecular diagnostics, and market growth projections until 2033.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.